Disclosures for "Solriamfetol Improves Cognitive Performance in Preclinical Models of Sleep Apnea and in a Randomized Placebo-controlled Study of Sleep Apnea Participants (SHARP)"
-
-
Prof. Van Dongen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Prof. Van Dongen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Prof. Van Dongen has received personal compensation in the range of $500-$4,999 for serving as a speaker at virtual meeting with American Academy of Sleep Medicine. Prof. Van Dongen has received personal compensation in the range of $0-$499 for serving as a reviewer with AAA Foundation.
-
Dr. Leary has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Leary has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proper. Dr. Leary has stock in Jazz Pharmaceuticals.
-
Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
-
Dr. Floam has received personal compensation for serving as an employee of Axsome Therapeutics.
-
Dr. Tabuteau has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Tabuteau has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axsome Therapeutics. Dr. Tabuteau has received stock or an ownership interest from Axsome Therapeutics. Dr. Tabuteau has received intellectual property interests from a discovery or technology relating to health care.